Last week, Eisai and Biogen announced significant results of its Phase 3 clinical trial of the drug lecanamab. Lecanamab is a monoclonal antibody that targets an early stage of the amyloid protein that forms plaques in the brains of people with Alzheimer’s disease. During an 18-month study in which 1795 participants received either drug or […]
Blog
Benefits of Clinical Trials: A Proactive Approach to Your Brain Health
What are Clinical Trials? Clinical trials are research studies in which treatments or diagnostic tools are tested for safety and efficacy. At The CRCNJ, we conduct clinical trials focused on memory loss, Alzheimer’s disease, Mild Cognitive Impairment, and dementia. What are the Benefits of Clinical Trials? Currently, 1 in 3 older adults die of Alzheimer’s […]
What Are Clinical Trials
What Are Clinical Trials? Clinical trials are research studies conducted to evaluate the safety and efficacy of a potential intervention or diagnostic tool. Each trial has specific criteria for participation, as well as a detailed protocol of assessments, timelines for participation, and drug administration (if applicable). Clinical intervention trials span an array of modalities or […]
Study Takes a New Approach to Alzheimer’s Disease by Focusing on the Gut
Scientists are exploring new types of medications to treat Alzheimer’s disease. The Green Memory study is novel, as it focuses on targeting the gut’s microbiome to determine if rebalancing certain bacteria with a naturally derived investigational medication would improve brain function and slow the progression of Alzheimer’s disease. This investigational medication has been approved for […]
Impacts of Social Isolation and COVID-19 on Brain Health
Cognitive health is being impacted by the COVID-19 pandemic. This could be due to a long-term effect of having had the virus, or the consequences of living through the pandemic. Older adults are particularly more vulnerable to the negative effects of social isolation, which can increase the likelihood of depression and anxiety, leading to decrease […]
Experimental Treatments for Alzheimer’s Disease
Alzheimer’s disease (AD) is a complicated disease process leading to a cascade of events in the brain. Based on an accumulation of research, it is believed that the initial trigger is an increase in a protein called abeta-42, referred to as amyloid beta. This protein sticks together and causes the formation of amyloid plaques that […]
